Site Search

... and partners are working together to make sure more Kentuckians can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers, are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

...   “Today, Michigan took an important first step to easing the burden of cancer and ensuring costs will not be a barrier to effective care. We’d like to thank the Senate, especially bill sponsor State Senator Goeff Hansen, for standing up for cancer patients.   “When offered ... some types of cancer are only treatable through oral medications, meaning that price tag can keep many patients from even accessing effective care. That’s a matter of life or death.   “Michigan has the opportunity to join most other states that have put these protections in place. We ... ACS CAN is the nonprofit, nonpartisan advocacy affiliate organization of the American Cancer Society, dedicated to eliminating cancer as a major health problem. ACS CAN works to encourage lawmakers, candidates and government officials to support laws and policies that will make cancer a top ...

... their story about access to biomarker testing. Video of additional_patient_stories_biomarkers   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...

... chosen by their insurance company – not their healthcare professional - before gaining access to the drug that was recommended to treat their health condition. When implemented inappropriately, step therapy can result in patients not being able to access the treatments they need in a ... disorders, HIV/AIDS, epilepsy, arthritis, psoriasis, heart disease, mental illness, multiple sclerosis Step Therapy/Fail First Policies Delay Care A survey of more than 1,400 patients conducted in 2016 by the Arthritis Foundation revealed that over half of all patients reported having to ... New Jersey. Reforming Step Therapy Means Ensuring That it is: ✔ Safe for patients ✔ Clinically grounded, and ✔ Transparent to patients and health care providers What does step therapy reform look like? Step therapy, also known as Fail First, is a process that requires patients to try ...